Napoletano, C., Ruscito, I., Bellati, F., Zizzari, I. G., Rahimi, H., Gasparri, M. L., . . . Nuti, M. (2019). Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets. J Clin Med.
Citación estilo ChicagoNapoletano, Chiara, et al. "Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients By Favoring the Recruitment of Effector T Cell Subsets." J Clin Med 2019.
Cita MLANapoletano, Chiara, et al. "Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients By Favoring the Recruitment of Effector T Cell Subsets." J Clin Med 2019.